Skip to main content
CVE-2025-57624VulnerabilityPublished Updated

CVE-2025-57624: n/a

Source CVE Database V5

0

Not known to be exploited · CVSS 7.8 High · fixed in 444 : patch affected systems soon.

Data as of 26 Oct 2026, 06:26 UTC

CVSS 3.1 base score
7.8High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.1% chance of exploitation in 30 days – higher than 4% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 444
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 16 Sep 2025

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-26.

What to do

AI-suggested

To mitigate CVE-2025-57624 effectively, European organizations should: 1) Immediately inventory all systems running CYRISMA Agent and identify versions prior to build 444. 3) Implement strict file system permissions to prevent unprivileged users from writing to directories where CYRISMA Agent loads DLLs, especially system and application directories. 4) Use application whitelisting or code integrity policies (e.g., Microsoft AppLocker or Windows Defender Application Control) to restrict execution of unauthorized DLLs. 5) Employ endpoint detection and response (EDR) solutions to monitor for suspicious DLL loading behavior and privilege escalation attempts. 6) Limit local user privileges and enforce the principle of least privilege to reduce the attack surface. 7) Conduct regular security awareness training to inform users about the risks of local privilege escalation and the importance of secure practices. 8) Consider isolating critical systems and restricting local access to trusted personnel only. These targeted steps go beyond generic advice by focusing on controlling DLL load paths, enforcing strict permissions, and leveraging advanced endpoint controls.

Description

A DLL hijacking vulnerability in CYRISMA Agent before 444 allows local users to escalate privileges and execute arbitrary code via multiple DLLs.

References

Community reviews

Loading reviews…